Anaphylaxis appears to be increasingly common and has been strongly associated with the increasing prevalence of allergic disease over the last two or three decades. The current COVID19 pandemic and development of potential vaccines will have an impact on healthcare professionals now having to administer vaccines to a much larger population. This also means we need to increase the number of clinicians administering the vaccine to meet demand.
The treatment of anaphylaxis needs a consistent approach which draws together relevant and appropriate expertise as provided by the Resuscitation Council (UK) and NICE clinical Guideline 134 recommendations.
This practical presentation will update participants’ knowledge of how to identify and manage anaphylaxis when administering a vaccine.
To have an awareness of current resuscitation guidelines on the management of anaphylaxis
Develop skills in early recognition and diagnosis of anaphylaxis during the vaccination programme.
Develop a structured approach in the immediate emergency treatment of anaphylaxis.
Lecturer: Lala Dizon, Lecturer /Practitioner and Resuscitation Officer
CPD: 1 hra